Literature DB >> 15965178

Subconjunctival corticosteroid injection for the treatment of non-necrotising anterior scleritis.

H N Sen, R Ursea, R B Nussenblatt, R R Buggage.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15965178      PMCID： PMC1772749          DOI： 10.1136/bjo.2004.052738

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  7 in total

1.  Subconjunctival corticosteroid injections for nonnecrotizing anterior scleritis.

Authors:  C R Croasdale; F S Brightbill
Journal:  Arch Ophthalmol       Date:  1999-07

2.  Episcleritis and scleritis: clinical features and treatment results.

Authors:  D A Jabs; A Mudun; J P Dunn; M J Marsh
Journal:  Am J Ophthalmol       Date:  2000-10       Impact factor: 5.258

3.  Evaluation of eyes enucleated for scleritis.

Authors:  F T Fraunfelder; P G Watson
Journal:  Br J Ophthalmol       Date:  1976-03       Impact factor: 4.638

4.  A prospective evaluation of subconjunctival injection of triamcinolone acetonide for resistant anterior scleritis.

Authors:  Ehud Zamir; Russell W Read; Ronald E Smith; Robert C Wang; Narsing A Rao
Journal:  Ophthalmology       Date:  2002-04       Impact factor: 12.079

5.  Evaluation of patients with scleritis for systemic disease.

Authors:  Esen Karamursel Akpek; Jennifer E Thorne; Faqir A Qazi; Diana V Do; Douglas A Jabs
Journal:  Ophthalmology       Date:  2004-03       Impact factor: 12.079

6.  An analysis of therapeutic decision for scleritis.

Authors:  M Sainz de la Maza; N S Jabbur; C S Foster
Journal:  Ophthalmology       Date:  1993-09       Impact factor: 12.079

7.  Therapy of nonnecrotizing anterior scleritis with subconjunctival corticosteroid injection.

Authors:  E Y Tu; W W Culbertson; S C Pflugfelder; A Huang; J C Chodosh
Journal:  Ophthalmology       Date:  1995-05       Impact factor: 12.079
  7 in total
  4 in total

1.  Long-term, multicenter evaluation of subconjunctival injection of triamcinolone for non-necrotizing, noninfectious anterior scleritis.

Authors:  Elliott H Sohn; Robert Wang; Russell Read; Athena Roufas; Livia Teo; Ramana Moorthy; Thomas Albini; Daniel V Vasconcelos-Santos; Laurie D Dustin; Ehud Zamir; Soon-Phaik Chee; Peter McCluskey; Ronald Smith; Narsing Rao
Journal:  Ophthalmology       Date:  2011-06-25       Impact factor: 12.079

2.  Subconjunctival sirolimus in the treatment of autoimmune non-necrotizing anterior scleritis: results of a phase I/II clinical trial.

Authors:  Nirali Bhatt; Monica Dalal; William Tucker; Dominic Obiyor; Robert Nussenblatt; H Nida Sen
Journal:  Am J Ophthalmol       Date:  2014-12-17       Impact factor: 5.258

Review 3.  Pharmacotherapy of scleritis: current paradigms and future directions.

Authors:  Robert M Beardsley; Eric B Suhler; James T Rosenbaum; Phoebe Lin
Journal:  Expert Opin Pharmacother       Date:  2013-02-21       Impact factor: 3.889

4.  Subconjunctival dexamethasone implant for non-necrotizing scleritis.

Authors:  Heloisa Nascimento; Maíra França; Luciana Guadalupe García; Cristina Muccioli; Rubens Belfort
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-01-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.